Epstein Secrets

ent should note that (i) Carlo Pirzio-Biroli and Charles Smith have been permanent voting members of the S

Japan. The information in relation to any interest and/ or investment has not been and will not be registered pursuant to Article 4, Paragraph 1 of the Financial Instruments and Exchange Law of Japan (Law no. 25 of 1948, as amended) (the "FIEL") and, accordingly, any interest and/or investment in them may not be offered

ent should note that (i) Carlo Pirzio-Biroli and Charles Smith have been permanent voting members of the S

Japan. The information in relation to any interest and/ or investment has not been and will not be registered pursuant to Article 4, Paragraph 1 of the Financial Instruments and Exchange Law of Japan (Law no. 25 of 1948, as amended) (the "FIEL") and, accordingly, any interest and/or investment in them may not be offered

ent should note that (i) Carlo Pirzio-Biroli and Charles Smith have been permanent voting members of the S

Japan. The information in relation to any interest and/ or investment has not been and will not be registered pursuant to Article 4, Paragraph 1 of the Financial Instruments and Exchange Law of Japan (Law no. 25 of 1948, as amended) (the "FIEL") and, accordingly, any interest and/or investment in them may not be offered

ent should note that (i) Carlo Pirzio-Biroli and Charles Smith have been permanent voting members of the S

Japan. The information in relation to any interest and/ or investment has not been and will not be registered pursuant to Article 4, Paragraph 1 of the Financial Instruments and Exchange Law of Japan (Law no. 25 of 1948, as amended) (the "FIEL") and, accordingly, any interest and/or investment in them may not be offered

herapeutics 1999 5.1 25.6 - 25.6 5.01 5.01 293.2% Charles River Laboratories Diagnostics & Infrastructure 1

ssly permitted by, and in compliance with, applicable law. JAPAN Interests in the Fund are a security set forth in Article 2, Paragraph 2, Item 6 of the Financial Instruments and Exchange Law of Japan (the “FIEL”). No public offering of interests in the Fund is being made to investors resident in Japan and in accordance wi